Current recommendations for management of paediatric diabetic ketoacidosis

Karen E Gripp1, Evelyne D Trottier1, Sidd Thakore1

  • 1Canadian Paediatric Society, Acute Care Committee, Ottawa, Ontario, Canada.

Insights

New evidence suggests early isotonic fluid therapy for pediatric diabetic ketoacidosis (DKA) may improve outcomes. Current guidelines now recommend initial fluid resuscitation to reduce risks like cerebral injury (CI).

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Metabolic Disorders

Background:

  • Diabetic ketoacidosis (DKA) in children requires careful fluid and electrolyte management to prevent severe complications like cerebral injury (CI).
  • Despite fluid-limiting protocols, the incidence of cerebral edema in pediatric DKA has not declined.
  • Emerging evidence challenges traditional fluid restriction, suggesting potential benefits of early isotonic fluid administration.

Purpose of the Study:

  • To review current evidence regarding fluid and electrolyte management in pediatric DKA.
  • To inform adjustments in clinical practice guidelines for treating DKA in children.
  • To assess the safety and efficacy of early isotonic fluid therapy in pediatric DKA.

Main Methods:

  • Review of recent studies and clinical evidence on fluid resuscitation in pediatric DKA.
  • Analysis of outcomes associated with different fluid therapy approaches.
  • Evaluation of current and proposed modifications to clinical practice guidelines.

Main Results:

  • New evidence indicates that early isotonic fluid therapy does not increase the risk of complications and may benefit some pediatric DKA patients.
  • Protocols are evolving to include initial isotonic fluid resuscitation within the first 20-30 minutes.
  • Treatment involves volume deficit repletion over 36 hours, insulin infusion, electrolyte support, and vigilant CI monitoring.

Conclusions:

  • Early isotonic fluid resuscitation is increasingly recommended for pediatric DKA.
  • Adjusted protocols emphasize timely fluid administration alongside insulin and electrolyte management.
  • Careful monitoring for cerebral injury remains critical throughout DKA treatment.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
321
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
30
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
56
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K